MIT student develops new innovations to selectively kill cancer cells
Date: 7.3.2009
When it comes to solving complex problems, Geoffrey von Maltzahn, MIT graduate student and **biomedical engineer**, looks to nature for solutions. Finding inspiration in systems that evolution has produced, von Maltzahn is currently helping to tackle one of society’s biggest challenges: improving **tumor detection** and **therapeutic delivery** in order to boost the survival rate of **cancer** patients.
Today, the 28-year-old Ph.D. candidate in the Harvard-MIT Division of Health Sciences and Technology (HST) received the prestigious $30,000 **Lemelson-MIT Student Prize** for his promising innovations in the area of **cancer therapy**, specifically two inventions in nanomedicine: a new class of cancer therapeutics and a new paradigm for enhancing drug delivery to tumors.
"Lemelson-MIT Program":[ http://mit.edu/invent/n-pressreleases/n-press-09SP.html]
